T. Lambin, A. Amiot, J.M. Gornet, P. Seksik, D. Laharie, E. Louis, C. Giletta, J. Filippi, M. Fumery, G. Cadiot, G. Pineton de Chambrun, S. Nahon, M. Serrero, B. Coffin, L. Plastaras, S. Viennot,…
Lire la suite
2020
Long-term outcome of Crohn’s disease patients with upper gastrointestinal stricture: a GETAID study
IMPACT OF AN EDUCATION PROGRAM ON IBD PATIENT’S SKILLS: RESULTS OF A RANDOMIZED CONTROLLED MULTICENTER STUDY (ECIPE)
J. Moreau, L. Marthey, C. Trang, M. Nachury, R. Altwegg, J.-C. Grimaud, S. Orempuller, J. Filippi, A. Aubourg, C. Baudry,P. Seksik, X. Roblin, S. Nahon, G. Savoye, B. Mesnard,C. Stefanescu, M. Simon, B. Coffin,…
Lire la suite
Surgery for Crohn’s disease during pregnancy: A nationwide survey
Germain A, Chateau T, Beyer-Berjot L, Zerbib P, Lakkis Z, Amiot A, Buisson A, Laharie D, Lefevre JH, Nancey S, Stefanescu C, Bresler L, Peyrin-Biroulet L (United European Gastroenterol J. 2020 Jul;8(6):736-740 – PMID: 32326876)…
Lire la suite
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Amiot A, Filippi J, Abitbol V, Cadiot G, Laharie D, Serrero M, Altwegg R, Bouhnik Y, Peyrin-Biroulet L, Gilletta C, Roblin X, Pineton de Chambrun G, Vuitton L, Bourrier A, Nancey S, Gornet JM,…
Lire la suite
Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients
Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N,…
Lire la suite
Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study.
Martin A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, Nancey S, Bourrier A, Serrero M, Fumery M, Buisson A, Laharie D, Gilletta C, Filippi J, Allez M, Bouguen G, Roblin X, Altwegg R, Dib N,…
Lire la suite
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease
Dulai PS, Amiot A, Peyrin-Biroulet L, Jairath V, Serrero M, Filippi J, Singh S, Pariente B, Loftus EV Jr, Roblin X, Kane S, Buisson A, Siegel CA, Bouhnik Y, Sandborn WJ, Lasch K, Rosario…
Lire la suite
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis
Pineton de Chambrun G, Amiot A, Bouguen G, Viennot S, Altwegg R, Louis E, Collins M, Fumery M, Poullenot F, Armengol L, Buisson A, Abitbol V, Laharie D, Seksik P, Nancey S, Blanc P,…
Lire la suite
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn’s Disease
Bouguen G, Huguet A, Amiot A, Viennot S, Cholet F, Nachury M, Flamant M, Reimund JM, Desfourneaux V, Boureille A, Siproudhis L (Clin Gastroenterol Hepatol. 2020 Mar;18(3):628-636 – PMID: 31128337) https://pubmed.ncbi.nlm.nih.gov/31128337/
Lire la suite
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease
Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D’Haens G, Vermeire S, Gils A (Clin Gastroenterol…
Lire la suite
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Lair-Mehiri L, Stefanescu C, Vaysse T, Laharie D, Roblin X, Rosa I, Treton X, Abitbol V, Amiot A, Bouguen G, Dib N, Fumery M, Pariente B, Carbonnel F, Peyrin-Biroulet L, Simon M, Viennot S,…
Lire la suite